OpenMFM Provider Education

Ischemic Placental Disease and
Postpartum Brain Health

A nationwide cohort of 17.4 million deliveries links preeclampsia, placental abruption, and fetal growth restriction to increased hospitalization for neurological and psychiatric disorders in the year following birth.

17.4 million deliveries, 2010–2020Nationwide Readmissions DatabasePhysician & MFM education

Source: Ananth CV, Chahal HS, Lee R, Rosenfeld EB, Suarez EA, Williams MA. Ischemic Placental Disease and Hospitalization for Neurological and Psychiatric Disorders. Am J Obstet Gynecol 2026. doi:10.1016/j.ajog.2026.07.008

Learning objectives

By the end of this deck, you should be able to answer four questions

  1. What is ischemic placental disease (IPD)? Recognize preeclampsia, placental abruption, and fetal growth restriction as a unified vascular syndrome, not three unrelated diagnoses.
  2. What did this study find? Quantify the magnitude of postpartum neurological and psychiatric hospitalization risk associated with IPD.
  1. Why does the risk vary? Understand the dose-response relationship with the number of IPD conditions and the plausible biological mechanism.
  2. What changes in practice? Identify what this evidence supports for postpartum counseling and surveillance — and what remains unproven.

Audience: physicians, residents, and advanced practice providers caring for pregnant and postpartum patients — obstetrics/gynecology and maternal-fetal medicine.

Background

Ischemic placental disease is one vascular syndrome with three clinical faces

Preeclampsia

Diffuse endothelial dysfunction and hypertension arising from placental ischemia.

Placental abruption

Premature placental separation, often on a background of decidual vasculopathy.

Fetal growth restriction

Impaired fetal growth from chronic uteroplacental insufficiency.

All three share a common upstream mechanism: inadequate physiological transformation of the uterine spiral arteries during implantation, producing uteroplacental ischemia, diffuse endothelial dysfunction, underperfusion, chronic hypoxia, and systemic oxidative stress.

Ananth & Vintzileos, Eur J Obstet Gynecol Reprod Biol 2011; Roberts, Semin Perinatol 2014.

Why this matters

Preeclampsia's brain risks are established — abruption and FGR were a blind spot

Already known
Hypertensive disorders of pregnancy

Women with a history of HDP show increased risk of cognitive impairment, psychiatric conditions including depression, and brain atrophy after an affected pregnancy — both in the short term and decades into the life course.

The gap this study fills
Abruption and FGR, at the population level

The long-term neurological effects of the other components of ischemic placental disease — particularly abruption and FGR — remained unknown before this study.

The authors broadly use the term “brain disorder” to encompass both neurological and psychiatric diagnoses throughout this study.

Study design

A population-based cohort of hospital deliveries, followed for brain-disorder readmission

17.4M

Deliveries

Hospital deliveries, ages 15–54, US Nationwide Readmissions Database, 2010–2020.

Cox PH

Model

Adjusted Cox proportional-hazards models for time to brain-disorder hospitalization.

2

Bias corrections

Quantitative bias analysis for outcome misclassification and unmeasured confounding.

1 yr

Follow-up

Readmissions tracked within the same calendar year as the delivery hospitalization.

Adjusted for: maternal age, pre-pregnancy diabetes, insurance payer, household income quartile, delivery year, hospital teaching status, hospital type, and bed size. Patients with a brain-disorder hospitalization before delivery in the same calendar year were excluded.

Healthcare Cost and Utilization Project (HCUP) Nationwide Readmissions Database. STROBE-adherent reporting.

Headline finding

Ischemic placental disease was associated with a 50% higher hazard of brain-disorder hospitalization

10.7%
of deliveries had recorded IPD
(n = 1,856,739)
1219 vs 730
brain-disorder hospitalizations
per 10,000 (IPD vs no IPD)
1.50
adjusted hazard ratio
(95% CI, 1.48–1.51)

Incidence proportion difference: 489 per 10,000 hospitalizations (95% CI, 479–499). Most brain-disorder hospitalizations were psychiatric — notably major depression, postpartum depression, and anxiety; migraine and epilepsy comprised most of the neurological diagnoses.

Neurological vs. psychiatric disorders

The neurological hazard was larger than the psychiatric hazard — but both were elevated

Neurological disorders
aHR 1.84 (1.81–1.86)
Psychiatric disorders
aHR 1.47 (1.46–1.49)

Neurological conditions studied

Epilepsy, migraine, stroke, and transient ischemic attack.

Psychiatric conditions studied

Major depression, postpartum depression, anxiety disorder, PTSD, psychosis/schizophrenia, bipolar disorder, and suicide attempt requiring hospitalization.

Dose-response relationship

Risk climbed steadily with each additional ischemic placental disease condition

Number of IPD conditionsAdjusted hazard ratio (95% CI)
NoneReference
One condition1.47 (1.46–1.49)
Two conditions1.66 (1.63–1.70)
All three conditions1.85 (1.70–2.01)

This progressive dose-response pattern — risk rising with each added IPD component — is consistent with cumulative vascular and inflammatory injury, rather than a single diagnosis-specific effect.

Isolated vs. combined components

Preeclampsia, abruption, and FGR carried similar risk alone — and more together

Condition, as isolated findingAdjusted hazard ratio (95% CI)
Preeclampsia alone1.52 (1.50–1.53)
Placental abruption alone1.48 (1.46–1.51)
Fetal growth restriction alone1.35 (1.34–1.37)
All three conditions together1.85 (1.70–2.01)

When considered in isolation, preeclampsia, abruption, and FGR carried similar magnitudes of hazard. Any two co-occurring conditions carried an intermediate risk between a single component and all three together.

Effect modification by age

The IPD–brain disorder disparity widened with advancing maternal age, up to 39 years

As overall hospitalization rates for any brain disorder rose with advancing maternal age, the gap between those with and without IPD widened in parallel. Age-specific adjusted hazard ratios for neurological disorders ranged from 1.75 to 1.84 across age strata.

A plateau or decline in this association after age 40 likely reflects smaller sample sizes, reduced statistical power, survivor bias (healthier individuals more likely to conceive at older ages), and differential healthcare utilization — not necessarily a true biological ceiling.

Kaplan-Meier survival curves for brain-disorder-free time showed no departure from the proportional-hazards assumption.

Robustness of the finding

The association survived correction for outcome misclassification and unmeasured confounding

AnalysisHazard ratio (95% CI)
Confounder-adjusted (primary analysis)1.50 (1.48–1.51)
Bias-corrected (misclassification + unmeasured confounding)1.50 (1.22–2.06)

Outcome misclassification: ICD-based diagnoses are imperfectly sensitive/specific (e.g., ~82%/95% for stroke, ~99%/70% for epilepsy). A probabilistic bias analysis (50 replications, beta and trapezoidal distributions) was applied.
Unmeasured confounding: a joint bounding-factor approach estimated how strong an unmeasured confounder would need to be to explain away the association.

Corrections widened the confidence intervals and slightly attenuated point estimates, but the association persisted in every scenario tested.

Proposed pathophysiology

A plausible pathway from placental ischemia to maternal brain vulnerability

Inadequate spiral-artery remodeling at implantationThe shared upstream defect across preeclampsia, abruption, and FGR
Uteroplacental ischemia + diffuse endothelial dysfunctionCirculating anti-angiogenic factors activate endothelium across vascular beds, including the cerebral vasculature
Systemic inflammation↑ TNF-α, IL-6, C-reactive protein
Neuroendocrine disruptionSex-steroid, cortisol, and HPA-axis dysregulation; altered serotonergic tone
Blood–brain barrier compromise → neuroinflammationMicroglial activation, neuronal injury, demyelination, disrupted synaptic connectivity
Neurological disordersEpilepsy, migraine, stroke, TIA
Psychiatric disordersDepression, anxiety, PTSD, psychosis, bipolar disorder

Mechanistic synthesis per Roberts & Gammill 2005; Siepmann et al. 2017; Zhao et al. 2022; Rosenfeld 2021 (placenta-brain axis).

Clinical implications

A pregnancy complicated by IPD is a sentinel event for postpartum brain health, not just cardiovascular risk

What is already recommended

Clinical practice guidelines recommend cardiovascular surveillance after a pregnancy affected by ischemic placental disease, based on strong epidemiologic and mechanistic evidence linking IPD to later cardiovascular disease.

What this study adds

Comparable formal guidance does not yet exist for neurological and psychiatric follow-up — but this study provides hospital-based evidence supporting the same principle: IPD identifies a population at heightened brain-health risk in the immediate postpartum period.

Consider a lower threshold for asking about mood, anxiety, headache, and neurological symptoms at postpartum visits in patients with a history of preeclampsia, abruption, or FGR — and counsel patients that these risks may compound with each additional IPD diagnosis.

Evidence & controversies

What's established, what's uncertain, and where the evidence stops short of proving causation

Known

IPD is associated with a 1.5- to 2.1-fold higher hazard of brain-disorder hospitalization within the year of delivery, with a clear dose-response by number of IPD conditions; the association persisted after bias correction.

Uncertain

Whether IPD causes brain dysfunction, unmasks pre-existing vulnerability, or reflects shared risk factors — the authors explicitly caution against a causal interpretation.

Contested / unmeasured

Parity, BMI, race/ethnicity, smoking/alcohol use, socioeconomic indicators, and trauma exposure were unavailable in this administrative dataset and could confound the association.

Research need

Prospective studies with pre-pregnancy neuroimaging, circulating biomarkers of endothelial function and neuroinflammation, and longitudinal neurocognitive assessment to test this mechanistic model and define postpartum screening protocols.

This cohort captures only inpatient hospitalizations — ambulatory visits and emergency-department-only encounters were missed. If IPD unmasks brain vulnerability this early, these estimates likely underestimate the true long-term neuropsychiatric burden.

Clinical pearls

Eight things to remember about ischemic placental disease and postpartum brain health

  1. IPD is one syndrome, three faces: preeclampsia, placental abruption, and FGR share a common origin in uteroplacental ischemia.
  2. IPD raised the hazard of any brain-disorder hospitalization by 50% (aHR 1.50) within the calendar year of delivery.
  3. Neurological hazard (aHR 1.84) exceeded psychiatric hazard (aHR 1.47) — but both were significantly elevated.
  4. Risk rose with each additional IPD condition: 1.47 → 1.66 → 1.85 for one, two, and three conditions.
  1. Preeclampsia, abruption, and FGR carried similar risk in isolation — this is not just a preeclampsia phenomenon.
  2. The disparity widened with maternal age, up to 39 years, suggesting a possible accelerated brain-aging phenotype.
  3. The association survived bias correction for outcome misclassification and unmeasured confounding, though causality remains unproven.
  4. These hospital-based estimates likely underestimate the true burden, since ambulatory and emergency-only encounters were not captured.
References

Selected references

  1. Ananth CV, Chahal HS, Lee R, Rosenfeld EB, Suarez EA, Williams MA. Ischemic Placental Disease and Hospitalization for Neurological and Psychiatric Disorders. Am J Obstet Gynecol. 2026. doi:10.1016/j.ajog.2026.07.008.
  2. Parker SE, Werler MM. Epidemiology of ischemic placental disease: a focus on preterm gestations. Semin Perinatol. 2014;38:133-8.
  3. Daggett EE, Ananth CV. Ischemic Placental Disease: Epidemiology and Impact on Maternal and Offspring Health Along the Life Course. Clin Obstet Gynecol. 2025;68:105-10.
  4. Roberts JM. Pathophysiology of ischemic placental disease. Semin Perinatol. 2014;38:139-45.
  5. Bakrania BA, et al. Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction. Compr Physiol. 2020;11:1315-49.
  6. Basit S, Wohlfahrt J, Boyd HA. Pre-eclampsia and risk of dementia later in life: nationwide cohort study. BMJ. 2018;363:k4109.
  7. Fields JC, Graham HL, Brandt JS, Bodenlos K, Ananth CV. Risk of postpartum readmission for depression in relation to ischaemic placental disease. EClinicalMedicine. 2023;60:102011.
  8. Elharram M, Dayan N, Kaur A, Landry T, Pilote L. Long-Term Cognitive Impairment After Preeclampsia: A Systematic Review and Meta-analysis. Obstet Gynecol. 2018;132:355-64.
  9. Bergink V, Burgerhout KM, Weigelt K, et al. Immune system dysregulation in first-onset postpartum psychosis. Biol Psychiatry. 2013;73:1000-7.
  10. Friis T, Bergman L, Hesselman S, et al. Gestational Hypertension, Preeclampsia, and Eclampsia and Future Neurological Disorders. JAMA Neurol. 2025;82:142-51.
  11. Nerenberg KA, Park AL, Vigod SN, et al. Long-term Risk of a Seizure Disorder After Eclampsia. Obstet Gynecol. 2017;130:1327-33.
  12. Blackman A, Ukah UV, Platt RW, et al. Severe Maternal Morbidity and Mental Health Hospitalizations or Emergency Department Visits. JAMA Netw Open. 2024;7:e247983.
  13. Caropreso L, de Azevedo Cardoso T, Eltayebani M, Frey BN. Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis. Arch Womens Ment Health. 2020;23:493-505.
  14. Siepmann T, Boardman H, Bilderbeck A, et al. Long-term cerebral white and gray matter changes after preeclampsia. Neurology. 2017;88:1256-64.
  15. Zhao Q, Dai W, Chen HY, et al. Prenatal disruption of blood-brain barrier formation via cyclooxygenase activation leads to lifelong brain inflammation. Proc Natl Acad Sci U S A. 2022;119:e2113310119.
  16. Rosenfeld CS. The placenta-brain-axis. J Neurosci Res. 2021;99:271-83.
  17. Grandi SM, Filion KB, Yoon S, et al. Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications. Circulation. 2019;139:1069-79.
  18. Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk. Circulation. 2021;143:e902-e16.
  19. Healthcare Cost and Utilization Project (HCUP). Nationwide Readmissions Database (NRD) Overview. Agency for Healthcare Research and Quality, 2022.

Educational summary of a peer-reviewed cohort study for physicians, residents, and advanced practice providers. Findings describe an association, not proven causation; verify current guidance before counseling individual patients.

Navigation

Next slidePrevious slideSpaceNext slideHomeFirst slideEndLast slideEscClose help
← OpenMFM Library